Some stroke patients whose life support is withdrawn may have achieved a less-than-ideal

February 7, 2013

More than a third of patients who suffer a major bleeding in the brain and have their life support withdrawn might have eventually regained an acceptable level of functioning if life support had been sustained, suggests a new study presented at the American Stroke Association's International Stroke Conference 2013.

In the United States, 10 percent of the estimated 795,000 strokes each year are intracerebral hemorrhages (ICH). ICH is the most common type of bleeding stroke and it occurs when a weakened blood vessel inside the brain ruptures and leaks blood into surrounding , causing .

The new study, initially encompassing 590 at a Seattle hospital, was designed to see whether "self-fulfilling prognostic ," might play a part in life-support decisions, said David Tirschwell, M.D., M.Sc., lead author and co-director of the University of Washington Stroke Center at Harborview, in Seattle.

Researchers identified 78 patients whose life support was withdrawn and compared their outcomes with 78 similar patients who were not removed from life support.

Researchers chose a disability rating of "moderately severe" or better as an "acceptable outcome." Moderately severe could mean patients are unable to attend to their own bodily needs or be unable to walk without assistance, Tirschwell said. He also acknowledged that "acceptable outcome" is up to each individual's perception and preferences.

At , only 4 percent of matched patients whose life support was withdrawn had an acceptable outcome, compared with 38 percent of the matches who did not have life support withdrawn—suggesting 34 percent of the group whose support was withdrawn might also have had an acceptable outcome if support had been sustained.

"Greater patience and less pessimism may be called for in making these life-and-death decisions," he said.

For their analysis, the researchers created a "propensity score" indicating the probability that a decision to withdraw life support would be made for a given ICH patient. The was based on a number of factors: age; functional status before the ICH; level of consciousness; how much bleeding occurred; pre-existing hypertension; diabetes; atrial fibrillation; first temperature measurement on the patient; and whether the patient was intubated for breathing support.

The strongest predictors of life support withdrawal—and the factors most crucial in the patient matching—were measures of the hemorrhage's severity, Tirschwell said.

"These results are yet another piece of evidence suggesting healthcare providers may be overly pessimistic in their assessments of these patients' prognoses, leading families to choose withdrawal of life support before the patient has had a chance to recover from their stroke," Tirschwell said.

Most decisions to withdraw life support are made by next of kin, in consultation with other relatives and with doctors, in the first few days of hospitalization after the ICH, he said. In that time frame, "it would be unrealistic to think the patient has had a chance to attain any measure of recovery," he said.

While "moderately severe" disability represents far-from-ideal capabilities, "the time of hospital discharge is likely only a couple of weeks after the ICH and recovery is a months-long process, and some of these patients—many even—might recover further," he said.

Tirschwell said the conclusions are based on the assumption of further recovery, which is known to be a long process and notoriously difficult to predict and the fact that quality of life is subjective. The study, conducted in one hospital, might not reflect practices at other institutions, Tirschwell said.

"The study does a commendable job measuring the effect on patient outcome of the decision-making process, probably the single most difficult factor to model," said Steven Greenberg, M.D., Ph.D., chair of the International Stroke Conference, Harvard Medical School neurology professor and director Hemorrhagic Stroke Research at Massachusetts General Hospital in Boston.

"The finding that fully a third of ICH patients in whom is withdrawn might otherwise survive is staggering" Greenberg said. "The major challenges in interpreting this finding are to determine whether patients can make further improvements after discharge, and if not, whether needing someone to help with walking, washing and other needs is an acceptable quality of life for them."

Explore further: Native Hawaiians have bleeding strokes at earlier age, independent of meth use

Related Stories

Native Hawaiians have bleeding strokes at earlier age, independent of meth use

February 6, 2013
Native Hawaiians and Pacific Islanders have more bleeding strokes at an earlier age than other people independent of methamphetamine abuse, according to research presented at the American Stroke Association's International ...

Study finds no link between intracerebral hemorrhage and statin use among patients with prior stroke

September 12, 2011
Among patients who have had an ischemic stroke, use of cholesterol-lowering statin medications is not associated with subsequent intracerebral hemorrhage (bleeding in the brain), according to a report published Online First ...

Cholesterol-lowering statin drugs can reduce the risk of stroke, but sometimes should be avoided

August 19, 2011
For many patients, cholesterol-lowering statin drugs can reduce the risk of strokes as well as heart attacks. But in a review article, Loyola University Health System neurologists caution that statins may not be appropriate ...

Withdrawing life support for traumatic brain injuries needs cautious approach

August 29, 2011
Death following severe traumatic brain injury is associated with a highly variable incidence of withdrawal of life support at the end of life, finds a new study in CMAJ. Rates of withdrawal of life support vary between hospitals, ...

Recommended for you

Five vascular diseases linked to one common genetic variant

July 27, 2017
Genome-wide association studies have implicated a common genetic variant in chromosome 6p24 in coronary artery disease, as well as four other vascular diseases: migraine headache, cervical artery dissection, fibromuscular ...

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.